IDSA GUIDELINES Bundle (free trial)

Leishmaniasis

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/774306

Contents of this Issue

Navigation

Page 32 of 39

33 Mitigation and Management Approaches d,f Pregnant Patients f,g Breastfeeding Patients f,h Comments Examples: premedication; saline loading ; test dose; slow infusions (~2–6 h); electrolyte supplementation, increased intervals between doses, and/ or drug holidays, if indicated. Avoid/ minimize use of other nephrotoxic agents (eg, nonsteroidal anti- inflammatory drugs). FDA pregnancy category B j Probably compatible (see Recs. 78-79); interruption of breastfeeding may be prudent. See above (eg, minimize use of other nephrotoxic agents) but modify as appropriate (eg, liposomal amphotericin B typically is infused over ~2 h; minimum of ~1 h). FDA pregnancy category B j (see Recs. 78-79)

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Leishmaniasis